For the Inventor, By the Inventor

Enter assignee name

Hospices Civils De Lyon

USPTO Granted Patents = 43

CIPO Patents = 5

EPO Patents = 49

Forward Citations = 51

Loading Chart...

Loading Chart...

120 inventors (with patents filed for the assignee):

Guillaume Monneret (10 out of 14 patents)

Fabienne Venet (7 out of 7 patents)

Alain Lepape (6 out of 9 patents)

4. Manuel Rosa-Calatrava (5 out of 9 patents)

5. Julien Textoris (4 out of 5 patents)

6. Toufic Renno (3 out of 3 patents)

7. Isabelle Coste-Invernizzi (3 out of 3 patents)

8. Serge Lebecque (3 out of 3 patents)

9. François Mallet (3 out of 8 patents)

10. Veronique Annie Rogemond (3 out of 4 patents)

11. Jean-Jacques Diaz (3 out of 3 patents)

12. Charles Dumontet (3 out of 3 patents)

13. Philippe Perot (3 out of 8 patents)

14. Stéphane Giraud (2 out of 2 patents)

15. Marie-Angelique Cazalis (2 out of 2 patents)

Core Competencies:

Infectious Disease Detection

Liposomal Formulation

Endoscopic Traction Device

Systemic Inflammatory Response Syndrome

Prostate Cancer Diagnosis

Antiviral Compositions

Dendronized Metallic Oxide Nanoparticles

Gene Therapy

Cancer Treatment

Immunological Status Assessment

Vaccine Antigen Preparation

Colorectal Cancer Treatment

43 patents: Sort by Forward Citations

1. 12509465 - Benzoimidazole derivatives as anticancer agents (2025-12-30),

2. 12482572 - Method for detecting an infectious transmission in a population (2025-11-25),

3. 12433838 - Liposomal formulation of bacterial lipopolysaccharide combined with a cytotoxic agent, and use thereof in anti-tumour therapy (2025-10-07),

4. 12376841 - Adjustable endoscopic traction device (2025-08-05),

5. 12110556 - Kit for assessing the risk of complications in patients with systemic inflammatory response syndrome (SIRS) (2024-10-08),

6. 11630101 - Method for diagnosing anomalies in the coagulation of blood (2023-04-18),

7. 11555191 - Inhibitor for use for preventing and/or treating an infection with hepatitis B virus (2023-01-17),

8. 11459605 - Method for the diagnosis or prognosis, in vitro, of prostate cancer (2022-10-04),

9. 11453916 - Method for in vitro diagnosis or prognosis of colon cancer (2022-09-27),

10. 11384081 - Benzoimidazole derivatives as anticancer agents (2022-07-12),

11. 11377690 - Method and kit for making an in vitro prognosis of severity for a patient in septic shock (2022-07-05),

12. 11351180 - Antiviral compositions for treating the flu (2022-06-07),

13. 11339438 - Method for assessing the risk of complications in patients with systemic inflammatory response syndrome (sirs) (2022-05-24),

14. 11299768 - Methods for determining a patient's susceptibility of contracting a nosocomial infection and for establishing a prognosis of the progression of septic syndrome (2022-04-12),

15. 11079391 - Biological marker for evaluating the IL-17 pro-inflammatory functional contribution dependent level in an individual (2021-08-03),

Hospices Civils de Lyon is a university hospital system in Lyon, France. It is the second-largest hospital system in France and one of the largest in Europe. The system operates multiple hospitals, clinics, and specialized centers, providing a wide range of medical services and treatments. With a rich history dating back to the 16th century, Hospices Civils de Lyon is renowned for its research, teaching, and innovative healthcare practices.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

43 Patents

#5 in Lyons

#520 in France

#15,583 in the World

Hospices Civils De Lyon

Forward Citations = 51

120 inventors:

Guillaume Monneret (10 out of 14 patents)

Fabienne Venet (7 out of 7 patents)

Alain Lepape (6 out of 9 patents)

4. Manuel Rosa-Calatrava (5 out of 9 patents)

5. Julien Textoris (4 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…